484 related articles for article (PubMed ID: 2189419)
1. Effects of pioglitazone on glucose and lipid metabolism in Wistar fatty rats.
Sugiyama Y; Taketomi S; Shimura Y; Ikeda H; Fujita T
Arzneimittelforschung; 1990 Mar; 40(3):263-7. PubMed ID: 2189419
[TBL] [Abstract][Full Text] [Related]
2. Effects of pioglitazone on glucose and lipid metabolism in normal and insulin resistant animals.
Ikeda H; Taketomi S; Sugiyama Y; Shimura Y; Sohda T; Meguro K; Fujita T
Arzneimittelforschung; 1990 Feb; 40(2 Pt 1):156-62. PubMed ID: 2334455
[TBL] [Abstract][Full Text] [Related]
3. Effects of pioglitazone on hepatic and peripheral insulin resistance in Wistar fatty rats.
Sugiyama Y; Shimura Y; Ikeda H
Arzneimittelforschung; 1990 Apr; 40(4):436-40. PubMed ID: 2192715
[TBL] [Abstract][Full Text] [Related]
4. Mechanism by which a novel non-thiazolidinedione peroxisome proliferator-activated receptor gamma agonist, FK614, ameliorates insulin resistance in Zucker fatty rats.
Minoura H; Takeshita S; Kimura C; Hirosumi J; Takakura S; Kawamura I; Seki J; Manda T; Mutoh S
Diabetes Obes Metab; 2007 May; 9(3):369-78. PubMed ID: 17391165
[TBL] [Abstract][Full Text] [Related]
5. Pioglitazone can ameliorate insulin resistance in low-dose streptozotocin and high sucrose-fat diet induced obese rats.
Ding SY; Shen ZF; Chen YT; Sun SJ; Liu Q; Xie MZ
Acta Pharmacol Sin; 2005 May; 26(5):575-80. PubMed ID: 15842776
[TBL] [Abstract][Full Text] [Related]
6. Pioglitazone-induced increase of insulin sensitivity in the muscles of the obese Zucker fa/fa rat cannot be explained by local adipocyte differentiation.
Hallakou S; Foufelle F; Doaré L; Kergoat M; Ferré P
Diabetologia; 1998 Aug; 41(8):963-8. PubMed ID: 9726600
[TBL] [Abstract][Full Text] [Related]
7. Metabolic recovery of adipose tissue is associated with improvement in insulin resistance in a model of experimental diabetes.
Takada J; Fonseca-Alaniz MH; de Campos TB; Andreotti S; Campana AB; Okamoto M; Borges-Silva Cd; Machado UF; Lima FB
J Endocrinol; 2008 Jul; 198(1):51-60. PubMed ID: 18451064
[TBL] [Abstract][Full Text] [Related]
8. Ameliorating effect of FK614, a novel nonthiazolidinedione peroxisome proliferator-activated receptor gamma agonist, on insulin resistance in Zucker fatty rat.
Minoura H; Takeshita S; Yamamoto T; Mabuchi M; Hirosumi J; Takakura S; Kawamura I; Seki J; Manda T; Ita M; Mutoh S
Eur J Pharmacol; 2005 Sep; 519(1-2):182-90. PubMed ID: 16039648
[TBL] [Abstract][Full Text] [Related]
9. Pioglitazone improves insulin signaling defects in skeletal muscle from Wistar fatty (fa/fa) rats.
Hayakawa T; Shiraki T; Morimoto T; Shii K; Ikeda H
Biochem Biophys Res Commun; 1996 Jun; 223(2):439-44. PubMed ID: 8670300
[TBL] [Abstract][Full Text] [Related]
10. In vitro insulin resistance of human adipocytes isolated from subjects with noninsulin-dependent diabetes mellitus.
Kashiwagi A; Verso MA; Andrews J; Vasquez B; Reaven G; Foley JE
J Clin Invest; 1983 Oct; 72(4):1246-54. PubMed ID: 6355180
[TBL] [Abstract][Full Text] [Related]
11. Improved metabolic status and insulin sensitivity in obese fatty (fa/fa) Zucker rats and Zucker Diabetic Fatty (ZDF) rats treated with the thiazolidinedione, MCC-555.
Upton R; Widdowson PS; Ishii S; Tanaka H; Williams G
Br J Pharmacol; 1998 Dec; 125(8):1708-14. PubMed ID: 9886762
[TBL] [Abstract][Full Text] [Related]
12. A comparison of glycemic control, water retention, and musculoskeletal effects of balaglitazone and pioglitazone in diet-induced obese rats.
Henriksen K; Byrjalsen I; Nielsen RH; Madsen AN; Larsen LK; Christiansen C; Beck-Nielsen H; Karsdal MA
Eur J Pharmacol; 2009 Aug; 616(1-3):340-5. PubMed ID: 19595686
[TBL] [Abstract][Full Text] [Related]
13. Effects of antihyperlipidemic agents on hepatic insulin sensitivity in perfused Goto-Kakizaki rat liver.
Matsuura B; Kanno S; Minami H; Tsubouchi E; Iwai M; Matsui H; Horiike N; Onji M
J Gastroenterol; 2004; 39(4):339-45. PubMed ID: 15168245
[TBL] [Abstract][Full Text] [Related]
14. Rosiglitazone improves insulin resistance, lipid profile and promotes adiposity in a genetic model of metabolic syndrome X.
Seda O; Kazdová L; Krenová D; Kren V
Folia Biol (Praha); 2002; 48(6):237-41. PubMed ID: 12512799
[TBL] [Abstract][Full Text] [Related]
15. Troglitazone increases the number of small adipocytes without the change of white adipose tissue mass in obese Zucker rats.
Okuno A; Tamemoto H; Tobe K; Ueki K; Mori Y; Iwamoto K; Umesono K; Akanuma Y; Fujiwara T; Horikoshi H; Yazaki Y; Kadowaki T
J Clin Invest; 1998 Mar; 101(6):1354-61. PubMed ID: 9502777
[TBL] [Abstract][Full Text] [Related]
16. Effects of pioglitazone and metformin on intracellular lipid content in liver and skeletal muscle of individuals with type 2 diabetes mellitus.
Teranishi T; Ohara T; Maeda K; Zenibayashi M; Kouyama K; Hirota Y; Kawamitsu H; Fujii M; Sugimura K; Kasuga M
Metabolism; 2007 Oct; 56(10):1418-24. PubMed ID: 17884455
[TBL] [Abstract][Full Text] [Related]
17. Pioglitazone: mechanism of action.
Smith U
Int J Clin Pract Suppl; 2001 Sep; (121):13-8. PubMed ID: 11594239
[TBL] [Abstract][Full Text] [Related]
18. Evidence that pioglitazone increases intracellular free magnesium concentration in freshly isolated rat adipocytes.
Nadler J; Scott S
Biochem Biophys Res Commun; 1994 Jul; 202(1):416-21. PubMed ID: 8037742
[TBL] [Abstract][Full Text] [Related]
19. Influence of the carnitine palmitoyltransferase inhibitor POCA on myocardial performance and metabolism of insulin resistant rats.
Rösen P; Reinauer H
Acta Physiol Hung; 1988; 71(2):271-80. PubMed ID: 3389170
[TBL] [Abstract][Full Text] [Related]
20. Improvement in in vitro insulin action after one month of insulin therapy in obese noninsulin-dependent diabetics. Measurements of glucose transport and metabolism, insulin binding, and lipolysis in isolated adipocytes.
Foley JE; Kashiwagi A; Verso MA; Reaven G; Andrews J
J Clin Invest; 1983 Dec; 72(6):1901-9. PubMed ID: 6358258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
